Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.560
-0.040 (-1.54%)
At close: Jun 27, 2025, 4:00 PM
2.600
+0.040 (1.56%)
After-hours: Jun 27, 2025, 7:53 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $354.00 million as of June 27, 2025. Its market cap has increased by 89.18% in one year.
Market Cap
354.00M
Enterprise Value
247.75M
1-Year Change
89.18%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $354.00M, a decrease of -18.68%. That is a compound annual growth rate of -4.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 329.11M | 64.97% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.24B |
| Johnson & Johnson | 367.34B |
| AbbVie | 329.49B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 277.00B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 234.37B |
| AstraZeneca | 215.99B |